Assembly Biosciences is a clinical stage biotechnology company which develops oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics. It is involved in developing core protein allosteric modulators that modulate the HBV core protein at various points in the viral lifecycle. The Company also develops microbiome program, a platform that includes the identification and selection process to strain isolation and growth under current good manufacturing practice conditions, and a patent pending delivery system, GEMICEL.

Employee Rating

5.0More
TypePublic
HQCarmel, US
Founded2005
Size (employees)69 (est)+36%
Websiteassemblybio.com
Assembly Biosciences was founded in 2005 and is headquartered in Carmel, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Assembly Biosciences

Derek Small

Derek Small

President & Chief Executive Officer, Director
Graham Cooper

Graham Cooper

Chief Financial Officer and Chief Operating Officer
Uri Lopatin

Uri Lopatin

Chief Medical Officer
Anthony Altig

Anthony Altig

Director
Mark Auerbach

Mark Auerbach

Director
Richard Dimarchi

Richard Dimarchi

Director
Show more

Assembly Biosciences Office Locations

Assembly Biosciences has offices in Carmel and San Francisco
Carmel, (HQ)
310 11711 N Meridian St
San Francisco,
409 Illinois St
Show all (2)
Report incorrect company information

Assembly Biosciences Financials and Metrics

Assembly Biosciences Revenue

USD

Net income (Q3, 2018)

(21.5m)

EBIT (Q3, 2018)

(22.6m)

Market capitalization (4-Dec-2018)

628.7m

Closing stock price (4-Dec-2018)

24.7

Cash (30-Sep-2018)

119.8m
Assembly Biosciences's current market capitalization is $628.7 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

General and administrative expense

4.6m11.3m12.2m17.0m

R&D expense

15.0m18.4m33.1m44.2m

Operating expense total

19.6m29.7m45.3m61.2m

EBIT

(19.6m)(24.0m)(29.7m)(45.3m)(52.2m)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

General and administrative expense

1.4m7.4m3.4m2.5m2.5m3.2m2.9m2.8m4.0m3.8m4.2m5.7m12.5m7.8m

R&D expense

1.1m3.7m3.8m4.7m4.6m8.1m7.5m8.8m10.6m12.1m10.9m14.5m17.8m19.1m

Operating expense total

2.5m11.1m7.2m7.2m7.1m11.3m10.5m11.7m14.6m15.9m15.1m20.2m30.4m26.9m

EBIT

(2.5m)(11.1m)(7.2m)(7.2m)(7.1m)(11.3m)(10.5m)(11.7m)(13.9m)(13.6m)(12.5m)(16.7m)(27.2m)(22.6m)
Annual
usdY, 2009Y, 2010Y, 2011Y, 2012FY, 2013Y, 2013Y, 2014Y, 2015FY, 2015FY, 2016FY, 2017

Cash

81.3k14.6m37.0m20.5m27.1m27.1m29.1m27.1m27.1m28.6m82.0m

Accounts Receivable

Inventories

611.2k

Current Assets

27.1m27.1m29.2m68.4m68.4m53.6m123.1m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

21.3m17.9m96.1m53.5m36.4m20.4m20.3m23.8m70.8m39.5m27.2m66.9m54.2m119.8m

Accounts Receivable

1.1m

Current Assets

21.7m18.1m96.3m71.3m66.5m59.1m64.1m59.3m92.2m77.7m68.7m113.2m97.5m239.9m

PP&E

173.2k174.0k156.5k132.2k113.7k128.5k182.8k131.9k593.1k731.5k639.9k515.8k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(19.4m)(23.8m)(28.5m)(44.3m)(42.8m)

Depreciation and Amortization

6.2k11.0k65.0k80.3k219.2k

Inventories

93.1k

Accounts Payable

(107.4k)(2.5m)456.1k1.0m(244.2k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(6.5m)(17.6m)(7.1m)(14.1m)(20.7m)(11.0m)(21.1m)(32.7m)(13.9m)(27.5m)(39.8m)(16.2m)(43.1m)(64.6m)

Depreciation and Amortization

2.3k3.9k30.4k47.9k18.6k37.1k55.3k31.9k82.8k124.7k168.1k311.9k473.4k

Accounts Payable

2.3m1.4m(1.2m)(2.5m)1.3m396.7k556.7k962.5k1.1m2.5m(420.9k)(1.7m)(1.5m)248.9k415.0k863.6k

Cash From Operating Activities

(7.5m)(11.4m)(8.1m)(13.2m)(9.2m)(16.0m)(23.8m)34.9m22.6m11.6m(15.5m)(31.5m)(48.2m)
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

Assembly Biosciences Online and Social Media Presence

Embed Graph
Report incorrect company information

Assembly Biosciences News and Updates

Assembly Biosciences Announces Third Quarter 2018 Financial Results and Provides HBV Program Update

ABI-H0731 Phase 2a Clinical Trials Actively Enrolling Patients; Data Continues to be Anticipated in 1H 2019
Report incorrect company information

Assembly Biosciences Blogs

Assembly Biosciences Presents Final Results of Phase 1b Study of ABI-H0731 at 2018 AASLD

Assembly Biosciences Presents Final Results of Phase 1b Study of ABI-H0731 at 2018 AASLD Content Import Mon, 11/12/2018 - 07:08 Assembly Biosciences Presents Final Results of Phase 1b Study of ABI-H0731 at 2018 AASLD November 12, 2018 at 7:05 AM EST This relea…

Assembly Biosciences Announces November Conference Participation

Assembly Biosciences Announces November Conference Participation Content Import Wed, 10/31/2018 - 07:03 Assembly Biosciences Announces November Conference Participation October 31, 2018 at 7:00 AM EDT This release is a backfill from a News Wire …

Assembly Biosciences Announces Oral Presentation at 2018 AASLD

Assembly Biosciences Announces Oral Presentation at 2018 AASLD Content Import Tue, 10/02/2018 - 07:07 Assembly Biosciences Announces Oral Presentation at 2018 AASLD October 2, 2018 at 7:05 AM EDT This release is a backfill from a News Wire Gener…

Assembly Biosciences Company Life and Culture

Report incorrect company information

Assembly Biosciences Frequently Asked Questions

  • When was Assembly Biosciences founded?

    Assembly Biosciences was founded in 2005.

  • Who are Assembly Biosciences key executives?

    Assembly Biosciences's key executives are Derek Small, Graham Cooper and Uri Lopatin.

  • How many employees does Assembly Biosciences have?

    Assembly Biosciences has 69 employees.

  • Who are Assembly Biosciences competitors?

    Competitors of Assembly Biosciences include Hansa Medical, Bioanalytical Systems (BASi) and Axsome Therapeutics.

  • Where is Assembly Biosciences headquarters?

    Assembly Biosciences headquarters is located at 310 11711 N Meridian St, Carmel.

  • Where are Assembly Biosciences offices?

    Assembly Biosciences has offices in Carmel and San Francisco.

  • How many offices does Assembly Biosciences have?

    Assembly Biosciences has 2 offices.